Maria L. Coniglio

Florence, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Encouraging Outcomes in Pediatric Malignancy-Associated Hemophagocytic Lymphohistiocytosis: Results From the Italian HLH Registry.

Encouraging Outcomes in Pediatric Malignancy-Associated Hemophagocytic Lymphohistiocytosis: Results From the Italian HLH Registry.

Journal: American journal of hematology
Published: December 11, 2025

The novel XIAP Lys396Ter variant alters mitochondrial membrane potential and endoplasmic reticulum intensity in monocytes of two XIAP-deficient patients.

The novel XIAP Lys396Ter variant alters mitochondrial membrane potential and endoplasmic reticulum intensity in monocytes of two XIAP-deficient patients.

Journal: Pediatric hematology and oncology
Published: June 25, 2025

Diagnostic impact of exome sequencing in haemophagocytic lymphohistiocytosis: A report from the Italian reference centre.

Diagnostic impact of exome sequencing in haemophagocytic lymphohistiocytosis: A report from the Italian reference centre.

Journal: British journal of haematology
Published: May 20, 2025

Neurodegenerative Langerhans cell histiocytosis: long-term follow-up of 63 patients from the Italian Registry.

Neurodegenerative Langerhans cell histiocytosis: long-term follow-up of 63 patients from the Italian Registry.

Journal: Haematologica
Published: May 11, 2025

Genetics of Familial Hemophagocytic Lymphohistiocytosis (HLH).

Genetics of Familial Hemophagocytic Lymphohistiocytosis (HLH).

Journal: Hematology/oncology clinics of North America
Published: April 08, 2025

Beyond genotype: challenges in predicting disease risk for carriers of biallelic perforin variants.

Beyond genotype: challenges in predicting disease risk for carriers of biallelic perforin variants.

Journal: Blood
Published: December 06, 2024

A multidisciplinary non-invasive approach to monitor response to intravenous immunoglobulin treatment in neurodegenerative Langerhans cell histiocytosis: a real-world study.

A multidisciplinary non-invasive approach to monitor response to intravenous immunoglobulin treatment in neurodegenerative Langerhans cell histiocytosis: a real-world study.

Journal: Frontiers in immunology
Published: April 25, 2024

Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited.

Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited.

Journal: Blood
Published: April 19, 2024

Vemurafenib combined with cytarabine and cladribine results in clinical efficacy but persistent BRAFV600E clone in a newborn affected by high-risk Langerhans cell histiocytosis.

Vemurafenib combined with cytarabine and cladribine results in clinical efficacy but persistent BRAFV600E clone in a newborn affected by high-risk Langerhans cell histiocytosis.

Journal: British journal of haematology
Published: April 17, 2024

Covid-19 pandemic and clinical activity stop: oral health study in a group of children.

Covid-19 pandemic and clinical activity stop: oral health study in a group of children.

Journal: European journal of paediatric dentistry
Published: February 07, 2024

Neurodegeneration in patients with multisystem Langerhans cell histiocytosis treated with vemurafenib.

Neurodegeneration in patients with multisystem Langerhans cell histiocytosis treated with vemurafenib.

Journal: British journal of haematology
Published: February 01, 2024

Unveiling the Role of Tryptophan 2,3-Dioxygenase in the Angiogenic Process.

Unveiling the Role of Tryptophan 2,3-Dioxygenase in the Angiogenic Process.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 24, 2024
Showing 1-12 of 30

Last Updated: 09/26/2026